Intrinsic Value of S&P & Nasdaq Contact Us

Select Medical Holdings Corporation SEM NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
$44.01
+168.7%
Analyst Price Target
$18.00
+9.9%

Select Medical Holdings Corporation (SEM) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $16.38. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of SEM = $44.01 (+168.7% from the current price, the stock appears undervalued). Analyst consensus target is SEM = $18 (+9.9% upside).

Valuation: SEM trades at a trailing Price-to-Earnings (P/E) of 13.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.28.

Financials: revenue is $5.5B, -3.9%/yr average growth. Net income is $146M, growing at +3.1%/yr. Net profit margin is 2.7% (thin). Gross margin is 11.5% (-0.1 pp trend).

Balance sheet: total debt is $3.7B against $1.7B equity (Debt-to-Equity (D/E) ratio 2.17, leveraged). Current ratio is 1.04 (adequate). Debt-to-assets is 63.3%. Total assets: $5.9B.

Analyst outlook: 5 / 13 analysts rate SEM as buy (38%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 80/100 (Pass), Growth 30/100 (Fail), Past 100/100 (Pass), Health 17/100 (Fail), Moat 42/100 (Fail), Future 40/100 (Partial), Income 30/100 (Fail).

$18.00
▲ 9.89% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for Select Medical Holdings Corporation, the average price target is $18.00, with a high forecast of $19.00, and a low forecast of $17.00.
Highest Price Target
$19.00
Average Price Target
$18.00
Lowest Price Target
$17.00

SEM SharesGrow Score Overview

48/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 80/100
Valuation — P/E, PEG, Forward PEG
GROWTH 30/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 42/100
Gross margin is + market cap
FUTURE 40/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SEM

VALUE Pass
80/100
SEM trades at a trailing Price-to-Earnings (P/E) of 13.8 (S&P 500 average ~25). Forward PEG 1.28 — ~moderate (~1.5). Trailing PEG 0.4. Analyst consensus target is $18, implying +9.9% from the current price $16. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Fail
30/100
SEM: -3.9%/yr revenue is, +3.1%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
SEM: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Fail
17/100
Balance sheet SEM: Debt-to-Equity (D/E) ratio 2.17 (leveraged), Current ratio is 1.04 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Fail
42/100
SEM: Gross margin is 11.5% (-0.1 pp trend), $2B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 42/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
40/100
Analyst outlook: 5 / 13 analysts rate SEM as buy (38%). Analyst consensus target is $18 (+9.9% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
SEM: Net profit margin is 2.7%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range11.65-18.61
Volume940.23K
Avg Volume (30D)1.98M
Market Cap$2.03B
Beta (1Y)0.97
Dividend Yield$0.2500
Share Statistics
EPS (TTM)1.18
Shares Outstanding$123.51M
IPO Date2009-09-25
Employees30,000
CEOThomas Mullin
Financial Highlights & Ratios
Revenue (TTM)$5.45B
Gross Profit$629.3M
EBITDA$530.64M
Net Income$146.22M
Operating Income$334.58M
Total Cash$26.52M
Total Debt$3.7B
Net Debt$3.68B
Total Assets$5.85B
Price / Earnings (P/E)13.9
Price / Sales (P/S)0.37
Analyst Forecast
1Y Price Target$18.00
Target High$19.00
Target Low$17.00
Upside+9.9%
Rating ConsensusHold
Analysts Covering13
Buy 38% Hold 54% Sell 8%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS81619Q1058

Price Chart

SEM
Select Medical Holdings Corporation  ·  NYSE
Healthcare • Medical - Care Facilities
11.65 52WK RANGE 18.61
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message